The new Cobas 6800/8800 systems 2.0 enhances throughput and run flexibility and enables sample prioritization.

The company has requested a hearing and paid a $20,000 fee to delay its delisting determination until Jan. 9, 2025.

NEW YORK – The US Attorney's Office for the District of New Jersey said Thursday that the owner of a New York-based consulting firm has pleaded guilty to charges related to a $5.3 million COVID-19 ...

The firm also has plans for tests beyond sepsis, including for cardiac events and other conditions that are commonly treated in acute care settings.

NEW YORK – Altona Diagnostics said on Thursday that it has received the European Union's In Vitro Diagnostic Regulation certification for the company's PCR-based tests, and the company plans to launch ...

The deal involves the implementation in Limbach Group labs of Noul's automated MiLab instrument that uses microscopy and AI-developed algorithms to analyze samples.

The PD-L1 IHC 28-8 PharmDx test is used to provide information on PD-L1 expression as a biomarker for patient response to therapies containing anti-PD-1 antibodies.

The organization now recommends HPV primary screening every five years starting at age 30 and includes patient-collected HPV screening.

The funding will support the development of the AmplifiDx Dx 100 Platform for use with a nucleic acid amplification test for respiratory infections.

The US Food and Drug Administration granted clearances to tests for infectious diseases, drug resistances, and chronic diseases, among other clearances.

The company also recently published multiple new clinical validation studies to support its quest for reimbursement.

The firm said its T2 Magnetic Resonance technology for testing whole-blood samples could be paired with fluorescence and other testing methods.